Abstract
Proteins of unknown function belonging to cog1816 and cog0402 were characterized. Sav2595 from Steptomyces avermitilis MA-4680, Acel0264 from Acidothermus cellulolyticus 11B, Nis0429 from Nitratiruptor sp. SB155-2 and Dr0824 from Deinococcus radiodurans R1 were cloned, purified, and their substrate profiles determined. These enzymes were previously incorrectly annotated as adenosine deaminases or chlorohydrolases. It was shown here that these enzymes actually deaminate 6-aminodeoxyfutalosine. The deamination of 6-aminodeoxyfutalosine is part of an alternative menaquinone biosynthetic pathway that involves the formation of futalosine. 6-Aminodeoxyfutalosine is deaminated by these enzymes with catalytic efficiencies greater than 105 M−1 s−1, Km values of 0.9 to 6.0 μM and kcat values of 1.2 to 8.6 s−1. Adenosine, 2′-deoxyadenosine, thiomethyladenosine, and S-adenosylhomocysteine are deaminated at least an order of magnitude slower than 6-aminodeoxyfutalosine. The crystal structure of Nis0429 was determined and the substrate, 6-aminodeoxyfutalosine, was positioned in the active site, based on the presence of adventitiously bound benzoic acid. In this model Ser-145 interacts with the carboxylate moiety of the substrate. The structure of Dr0824 was also determined, but a collapsed active site pocket prevented docking of substrates. A computational model of Sav2595 was built based on the crystal structure of adenosine deaminase and substrates were docked. The model predicted a conserved arginine after β-strand 1 to be partially responsible for the substrate specificity of Sav2595.
Menaquinone can be biosynthesized through either the shikimate pathway or the futalosine pathway. In Escherichia coli, the well-studied shikimate pathway utilizes seven enzymes (menA to menG) to convert chorismate into menaquinone (1). Recently, menaquinone producing organisms were identified that lack menF, menD, menC, menE, and menB orthologs (2, 3). These organisms, including Streptomyces coelicolor A3(2), Helicobacter pylori, Campylobacter jejuni, and Acidothermus cellulolyticus, lack men gene homologs and were suspected of employing a different pathway for the biosynthesis of menaquinone (1, 4). Using a combination of bioinformatics and gene disruption experiments, the mqn genes involved in the futalosine pathway were identified (Figure 1) (1). Mqn genes are found scattered throughout the genomes, with the exception of A. cellulolyticus, which has two clusters of menaquinone related genes (4). The smaller cluster contains MqnC and MqnB orthologs and the other cluster is made up of several genes, including MqnA, another MqnC and an adenosine deaminase ortholog (Acel0264) (Figure 2).
Adenosine deaminase is a member of the amidohydrolase superfamily (AHS) of enzymes: a superfamily first identified by Holm and Sander based on the similarities in the three-dimensional structures of phosphotriesterase, adenosine deaminase and urease (5). The common fold within the AHS is a distorted (β/α)8-barrel with conserved metal binding residues at the C-terminal ends of β-strands 1, 4, 5, 6, and 8. Enzymes in the AHS have either a mononuclear or binuclear metal center that functions to activate a water molecule for nucleophilic attack on amino acids, sugars, nucleic acids and organophosphate esters (6). The AHS is composed of 24 clusters of orthologous groups (COG). Enzymes that are known to deaminate aromatic bases are found in cog1001, cog0402 and cog1816. Members of cog1001 include the prototypical adenine deaminase (ADE) and N-6-methyladenine deaminase (7). Enzymes that deaminate guanine, cytosine, S-adenosylhomocysteine, thiomethyl adenosine, N-formimino-L-glutamate, and 8-oxoguanine are found in cog0402 (8). According to annotations reported by NCBI, bacterial enzymes in cog1816 function in the deamination of adenosine. The functional diversity of cog1816 has recently been expanded to include enzymes that deaminate adenine and cytokinins (9, 10). The mechanism, structure and biological function of adenosine deaminase enzymes from several organisms have been investigated (11–23). A sequence similarity network for cog1816 is illustrated in Figure 3 at a BLAST E-value of 1 × 10−70, which corresponds to a sequence identity within each group of ~30% (24). In general, members of a group share a common function, and the substrate profiles differ between groups. Members of group 5 of cog1816 are prototypical adenosine deaminases, including the adenosine deaminase from E. coli K-12. Group 3 of cog1816 includes adenine deaminases with a single divalent cation and enzymes that catalyze the deamination of cytokinins.
The initial targets for this investigation were the functional annotation of Acel0264 from A. cellulolyticus and Sav2595 from Streptomyces avermitilis MA-4680. These enzymes belong to groups 11 and 13 of cog1816, respectively. The substrate profile for these two enzymes has been established and a three-dimensional model has been proposed for how the best substrate, 6-aminodeoxyfutalosine (AFL), binds in the active site. Based on the absence of men genes in the genomes of Deinococcus radiodurans R1 and Nitratiruptor sp. SB155-2, two distantly related enzymes from cog0402, Dr0824 from D. radiodurans R1 and Nis0429 from N. sp. SB155-2, were identified as 6-aminodeoxyfutalosine deaminases. The three dimensional structures of Dr0824 and Nis0429 were determined by X-ray crystallography. A sequence similarity network of cog0402, which includes guanine deaminase, cytosine deaminase and other deaminases, is shown in Figure 4.
MATERIALS and METHODS
Materials
All chemicals were purchased from Sigma-Aldrich, unless otherwise stated. 6-Aminodeoxyfutalosine (AFL) was synthesized as previously described (25). 1-(6-Amino-9H-purin-9-yl)-1-deoxy-N-ethyl-β-D-ribofuranuronamide (NECA) was purchased from Ascent Scientific.
Cloning and Purification of Sav2595 from Streptomyces avermitilis MA-4680 and Dr0824 from Deinococcus radiodurans R1
The genes for Sav2595 and Dr0824 were cloned from the genomic DNA of Streptomyces avermitilis MA-4680 and Deinococcus radiodurans R1, respectively. The PCR products were amplified using the primer pairs 5′-AGAGCCATGGTGACCGAGCACTTCGACGC -3′ and 5′-AGAGAAGCTTCAGGGCGCGAGCCATGCC-3′, and pair 5′-GGGAATTACCATATGCGCTTTTCTGCCGTCAGCCG -3′ and 5′-CCCAAGCTTTCATCACAAGTCGCGGCTCAACTCCCAACG -3′, respectively. The restriction sites for NcoI and HindIII for Sav2595, and NdeI and HindIII for Dr0824 were inserted into the forward and reverse primers, respectively. The PCR products were purified with a PCR clean-up system (Qiagen), digested with their respective restriction enzymes and ligated into a pET-30a(+) vector, which was previously digested with the same two restriction enzymes. The cloned gene fragments were sequenced to verify fidelity of the PCR amplification. Dr0824 contains a C-terminal polyhistidine tag, whereas Sav2595 has an N-terminal polyhistidine tag.
Sav2595-pET-30a(+) and Dr0824-pET30a(+) constructs were transformed into BL21(DE3) cells (Novagen). A single colony was used to inoculate a 5 mL overnight culture of LB medium containing 50 μg/mL kanamycin. Each overnight culture was used to inoculate 1.0 L of LB medium containing 50 μg/mL kanamycin. One liter cultures were grown at 37 °C, supplemented with 1.0 mM ZnCl2 and induced with 0.5 mM isopropyl D-thiogalactopyranoside (IPTG) when an OD600 of 0.6 was reached. Cultures of Dr0824 were induced with 1.0 mM IPTG. At the time of induction, the temperature was lowered to 20 °C and allowed to shake for 18 hours before the cells were harvested by centrifugation at 8,000 rpm for 10 minutes. The cells were resuspended in 20 mM HEPES buffer, pH 7.5, containing 20 mM imidazole, 120 mM ammonium sulfate, 10% glycerol, 0.1 mg/mL phenylmethanesulfonyl fluoride (PMSF) and 0.5 mg/mL deoxyribonuclease I from bovine pancreas. Cells were lysed by sonication and the soluble protein was separated from the cell debris by centrifugation. Soluble protein from cultures of Sav2595 was loaded onto a HisTrap column (GE Healthcare) and eluted with a linear gradient of a solution containing 20 mM HEPES, pH 7.5, imidazole, 500 mM imidazole, and 500 mM ammonium sulfate. Soluble protein from cultures of Dr0824 was partitioned by ammonium sulfate precipitation at 30, 50 and 70% saturation. The precipitated protein (30–50% ammonium sulfate saturation) was re-suspended in 50 mM HEPES buffer (pH 7.7) and applied to a High Load 26/60 Superdex 200 preparative grade gel filtration column (GE Healthcare). Fractions containing protein were pooled and passed through an anion exchange column.
Cloning and Purification of Acel0264 from Acidothermus cellulolyticus
The gene for Acel0264 was amplified from Acidothermus cellulolyticus Strain 11B genomic DNA using 5′-TTAAGAAGGAGATATACCATGGTGATGACACCCCACGATCCCGTC -3′ as the forward primer and 5′-GATTGGAAGTAGAGGTTCTCTGCCAGCGACTCTCCCGCCGCTG -3′ as the reverse primer. PCR was performed using KOD Hot Start DNA Polymerse (Novagen). The amplified fragment was cloned into the C-terminal TEV cleavable C-terminal StrepII-6x-His-tag containing vector, CHS23, by ligation-independent cloning (26).
The gene for Acel0264 inserted in a CHS23 vector was transformed into Rosetta2 (DE3) cells (Novagen). A single colony was used to inoculate a 5 mL overnight culture of LB medium containing 50 μg/mL kanamycin and 25 μg/mL chloramphenicol. Each overnight culture was used to inoculate 1.0 L of LB medium containing 50 μg/mL kanamycin and 25 μg/mL chloramphenicol. One liter cultures were grown at 37 °C. At an OD600 of 0.6, 1.0 mM ZnCl2 was added, followed by induction with 50 μM IPTG. At the time of induction, the temperature was lowered to 20 °C and allowed to shake for 18 hours before the cells were harvested by centrifugation at 8,000 rpm for 10 minutes. The cells were resuspended in 20 mM HEPES buffer, pH 6.5, with 120 mM ammonium sulfate and 20 mM imidazole. Cells were lysed by sonication in the presence of 0.1 mg/mL PMSF and 0.5 mg/mL deoxyribonuclease I from bovine pancreas. Soluble protein was separated from the cell debris by centrifugation. The protein was then loaded onto a HisTrap HP column (GE Healthcare) and eluted with a gradient of buffer containing 20 mM HEPES, 500 mM imidazole and 500 mM ammonium sulfate, pH 6.5.
Cloning and Purification of Nis0429 from Nitratiruptor sp. SB155-2
The gene encoding Nis0429 was chemically synthesized and cloned into the plasmid pUC57 (GenScript). Expression constructs were generated by PCR amplification using the 5′-TTAAGAAGGAGATATACCATGCGTATCATTAAGCCGTTCGCC-3′ as the forward primer and the 5′-GATTGGAAGTAGAGGTTCTCTGCTTCGCGGACGTGTTCTTCGCC-3′ as the reverse primer. PCR was performed using KOD Hot Start DNA Polymerase (Novagen). The conditions were: 2 minutes at 95 °C, followed by 40 cycles of 30 seconds at 95 °C, 30 seconds at 66 °C, and 30 seconds at 72 °C. The amplified fragment was cloned into the C-terminal TEV cleavable C-terminal StrepII-6x-His-tag containing vector, CHS30, by ligation-independent cloning (26).
Expression vectors were transformed into E. coli BL21(DE3) containing the pRIL plasmid (Stratagene) and used to inoculate a 25 mL M9 minimal media culture containing 25 μg/mL kanamycin and 34 μg/mL chloramphenicol. The culture was allowed to grow overnight at 37 °C in a shaking incubator. A 10 mL aliquot of the overnight culture was used to inoculate 2 L of M9 SeMET high-yield medium (Shanghai Medicilon) supplemented with 150 mM 2, 2′-bipyridyl, 1.0 mM ZnCl2, and 1.0 mM MnCl2. The culture was placed in a LEX48 airlift fermenter and incubated at 37 °C until the OD600 reached 1.2. Cells were induced by addition of 0.5 mM IPTG and allowed to grow for 16 hours at 22 °C overnight. The culture was harvested and pelleted by centrifugation.
Cells were re-suspended in lysis buffer containing 20 mM HEPES, pH 7.5, 500 mM NaCl, 20 mM imidazole, and 10% glycerol and lysed by sonication. Lysates were clarified by centrifugation at 35,000g for 30 minutes. Proteins were purified on an AKTAxpress FPLC (GE Healthcare). Clarified lysates were loaded onto a 5 mL Strep-Tactin column (IBA), washed with 5 column volumes of lysis buffer, and eluted with 20 mM HEPES, pH 7.5, 500 mM NaCl, 20 mM imidazole, 10% glycerol, and 2.5 mM desthiobiotin. The eluent was loaded onto a 1 mL Histrap HP column (GE Healthcare), washed with 10 column volumes of lysis buffer, and eluted with 20 mM HEPES, pH 7.5, 500 mM NaCl, 500 mM imidazole, and 10% glycerol. The purified sample was applied to a HiLoad S200 16/60 HR gel filtration column which was equilibrated in 20 mM HEPES, pH7.5, 150 mM NaCl, 10% glycerol, and 5 mM DTT. Peak fractions were collected and protein was analyzed by SDS-PAGE. Samples were concentrated to 18 mg/mL using Amicon Ultra centrifugal filters (Millipore), snap frozen in liquid nitrogen, and stored at −80 °C.
Initial Activity Screens
Sav2595, Acel0264, Dr0824, and Nis0429 (5 IM) were incubated for 16 hours with AFL, adenine, adenosine, 2′-deoxyadenosine, 3′-deoxyadenosine, 5′-deoxyadenosine, 2′-5′-dideoxyadenosine, AMP, ADP, ATP, S-adenosylhomocysteine, S-adenosyl methionine, N-6-methyl-2′-deoxyadenosine, 5′-thiomethyladenosine, formaminopyrimidine-adenine, and NECA. The substrate concentration was 80 μM. Enzymatic activity was monitored by changes in absorbance between 240–300 nm with a SPECTRAmax Plus spectrophotometer (Molecular Devices).
Measurement of Kinetic Constants
Assays were conducted with substrate concentrations of 4–200 μM. The deamination of AFL, NECA, adenosine, AMP, 2′-deoxyadenosine, 3′-deoxyadenosine, 5′-deoxyadenosine, SAH and 5′-methylthioadenosine was monitored by following the decrease in absorbance at 263 nm. Differential extinction coefficients were calculated by subtracting the extinction coefficient of the product from that of the substrate for AFL, adenosine, NECA, 5′-methylthioadenosine, 5′-deoxyadenosine, SAH and AMP (Δε263 = 6900 M−1 cm−1).
Metal Analysis
Metal content of the proteins was determined by ICP-MS (27). Protein samples for ICP-MS were digested with HNO3 by refluxing for ~45 minutes to prevent protein precipitation during the measurement. Protein concentration was adjusted to ~1.0 μM with 1% (v/v) HNO3.
Data Analysis
Sequence alignments were created using Clustal (28). Steady state kinetic data were analyzed using Softmax Pro, version 5.4 (Molecular Devices). Kinetic parameters were determined by fitting the data to equation 1 using the nonlinear least-squares fitting program in SigmaPlot 11.0 (Systat Software Inc.). In this equation, A is the substrate concentration, Km is the Michaelis constant, v is the velocity of the reaction and kcat is the turnover number.
(1) |
Homology Modeling and Ligand Docking
The X-ray structure of adenosine deaminase from Bos taurus with a transition-state analogue bound in the active site (PDB ID: 1KRM, 26% and 25% sequence identity to Acel0264 and Sav2595, respectively) was used as the template to build homology models for Acel0264 and Sav2595. The sequence alignment was computed with Multiple Sequence Comparison by Log-Expectation (MUSCLE) (29) followed by generation of 500 homology models using the standard “automodel” class in MODELLER 9v12 (30). The model with the best DOPE (31) score was selected and this initial model was refined with the “loopmodel” class in MODELLER and the side chain prediction protocol in PLOP (32). After refinement, the two homology models of Acel0264 and Sav2595 were targeted by docking screens using DOCK 3.6 (33, 34) with a virtual library (35–37) that contains NECA, AFL, as well as 57680 different high-energy intermediates (HEI) of 6440 KEGG (Kyoto Encyclopedia of Genes and Genomes) molecules (38, 39). In docking screens, a computed pose was selected if the O− moiety of the HEI portion of the molecule was found within 4 Å of the metal ion in the active site. The selected molecules were ranked by an energy function consisting of protein-ligand van der Waals interactions, protein-ligand electrostatic interactions, and a correction for ligand desolvation. The top 500 ranked molecules were inspected visually to ensure the compatibility of the pose with the amidohydrolase reaction mechanism.
Mutation of Sav2595 and Nis0429
Single-site mutations of Sav2595 were constructed using the standard QuikChange PCR protocol according to the manufacturer’s instructions. The mutants, R87A and R87M, were expressed and purified using the protocol established for wild-type Sav2595. A single-site mutation was made to Nis0429 through standard QuikChange PCR protocols to create the S145A mutant.
Structure Determination of Dr0824
Crystals were grown by mixing 1 μL protein with 1 μL reservoir solution via the sitting drop vapor diffusion method. Protein was in HEPES buffer at pH 7.5 at a concentration of approximately 14 mg/mL. Reservoir solution contained 30% PEG MME500, 0.1 M BisTris, pH 6.5, and 50 mM calcium chloride. Harvested crystals were mounted in cryo-loops and immediately flash-cooled in liquid nitrogen. Diffraction from these crystals was consistent with the monoclinic space group C2 and data extending to 1.78 Å resolution collected on the X12C beam-line of the National Synchrotron Light Source (NSLS), Brookhaven National Laboratory. Data were processed, integrated, and scaled using HKL2000 (40); data collection parameters are given in Table 1. The structure was determined by single anomalous dispersion (SAD) using Se-Met substituted crystals. Se-Met crystals were obtained under the same conditions that yielded native crystals. Se atoms were located using SOLVE and the phases were refined with SHARP (41, 42). The initial protein model was built by an automated procedure using ARP/wARP software (43). The model was completed manually using ‘O’ and water molecules added based on the Fourier difference map (44). The structure was refined with CNS 1.1 and the refinement statistics are presented in Table 1 (45). The final model contains a zinc ion in addition to protein atoms and 170 water molecules (PDB ID: 2IMR).
Table 1.
PDB identifier | 2IMR | 3V7P | 4M51 |
---|---|---|---|
Space group | C 1 2 1 | C 1 2 1 | C 1 2 1 |
Unit cell dimension (Å) | |||
-a | 113.83 | 91.515 | 92.163 |
-b | 71.30 | 75.169 | 75.788 |
-c | 51.34 | 75.646 | 76.291 |
Cell angles (degrees) | |||
-alpha | 90.00 | 90.00 | 90.00 |
-beta | 115.20 | 120.72 | 120.99 |
-gamma | 90.00 | 90.00 | 90.00 |
Molecules per ASU | 1 | 1 | 1 |
Solvent content | 40.24 | 47.01 | 47.03 |
Matthew’s Coefficient | 2.06 | 2.32 | 2.33 |
Ligands | Zn2+ | benzoate tartrate unknown Fe2+ | benzoate sulfate HEPES Fe2+ |
X-ray source | NSLS X12C | NSLS X29A | NSLS X29A |
Wavelength | 0.9795 | 1.075 | 1.075 |
Method of structure solution | SAD | SAD | molecular replacement |
Resolution | 29.30–1.78 (1.84–1.78) | 70.00–1.35 (1.38–1.35) | 33.91–1.08 (1.10–1.08) |
Resolution/refinement | 29.30–1.78 | 50.00–1.35 | 33.91–1.08 |
Completeness (%) | 95.3 (64.7) | 99.6 (94.3) | 95.1 (91.1) |
I/sigma (I) | 19.20 (3.30) | 9.00 (1.30) | 10.20 (2.50) |
Rsym | 0.048 (0.364) | 0.051 (0.730) | 0.061 (0.640) |
Rwork (Rfree) | 20.1 (23.0) | 12.8 (16.1) | 11.8 (13.5) |
Rfree reflections (%) | 1321 (5.0%) | 2889 (3.0%) | 5505 (3.0%) |
Average B factor | 24.11 | 24.77 | 16.48 |
RMSD | |||
-bonds lengths | 0.005 | 0.012 | 0.012 |
-bond angles | 1.310 | 1.389 | 1.614 |
Number of solvent molecules | 170 | 226 | 609 |
Ramachandran plot statistics | |||
Most favored regions | 97.1% | 96.9% | 96.4% |
Allowed regions | 2.6% | 2.9% | 3.4% |
Outliers | 0.27% (His301) | 0.25% (His257) | 0.25%(His257) |
Structure Determination of Nis0429
Se-Met derivatized protein was crystallized by the sitting-drop vapor diffusion method, as described below. 0.5 μL of the protein solution (18 mg/mL) was mixed with an equal volume of a precipitant solution and equilibrated at room temperature (294 K) against the same precipitant solution in clear tape-sealed 96-well INTELLI-plates. Crystallization was performed using a TECAN crystallization robot. A single crystal appeared approximately 11 months after setting up crystallization drops in 0.1 M MES/NaOH, pH 6.0, 1 M potassium sodium tartrate. This crystal was flash-cooled in liquid nitrogen prior to data collection.
Two complete X-ray diffraction data sets were collected from the same crystal at 100 K on the beamline X29A at NSLS using wavelengths of 1.075 Å (the resolution cutoff was 1.35 Å) and 0.979 Å (the resolution cutoff was 1.5 Å), respectively. All data were processed and scaled with HKL2000 (40). The crystal structure was determined by selenium-SAD applying anomalous X-ray diffraction data (collected at a wavelength of 0.979 Å) for phasing and SHELXD software (the CCP4 program package suite (46, 47). The structure was further refined using a higher resolution “native” data (resolution 1.35 Å) and the program REFMAC (48). The model was rebuilt and fixed manually using COOT visualization and refinement software (49). The data collection and refinement statistics are listed in Table 1. The coordinates and structure factors were deposited to the Protein Data Bank (PDB ID: 3V7P).
Structure Determination of the S145A mutant of Nis0429
The purified S145A protein was concentrated to about 38 mg/mL and crystallized as described above for the wild-type Nis0429 using a PHOENIX crystallization platform and four different MCSG crystallization screens. Protein crystals appeared in two to three weeks. The crystals were directly flash frozen in liquid nitrogen. The 1.08 Å resolution X-ray diffraction data were collected on the beamline X29A (NSLS) at a wavelength of 1.075 Å and a temperature of 100 K. The data were processed and scaled with HKL2000 (40). The crystal of the S145S mutant of Nis0429 was essentially isomorphous to that of the wild-type protein (PDB ID: 3V7P), and thus the coordinates of the latter were used to build and subsequently refine the structure of the mutant using the program REFMAC (48) and a COOT visualization and refinement software (49). The final refinement statistics altogether with data collection parameters are listed in Table 1. The coordinates and structure factors were deposited in the Protein Data Bank (PDB ID: 4M51).
RESULTS
Protein Isolation
The enzymes studied in this investigation belong to groups 11 and 13 of cog1816 and groups 7 and 41 of cog0402 (Figures 3 and 4). Sav2595, Acel0264, Dr0824, and Nis0429 were expressed in E. coli and purified to homogeneity. Despite supplementing the growth medium with 1.0 mM ZnCl2, the metal content of all proteins was low. Sav2595 contained an average of 0.1 equivalent of Zn2+ per subunit. Acel0264 contained an average of 0.4 equivalent of Zn2+ and 0.1 equivalent of Ni2+ per monomer. Both proteins were incubated overnight with ZnCl2, but no increase in catalytic activity was observed after incubation. Dr0824 contained 0.8 equivalents of Mn2+. Nis0429 contained 0.5 equivalents of Zn2+ and 0.1 equivalent each of Fe2+ and Mn2+.
Substrate Specificity
The substrate profiles of Sav2595, Acel0264, Dr0824, and Nis0429 were initially determined by monitoring changes in absorbance between 240–300 nm using a small library of modified adenosine derivatives. The best substrate for these four enzymes is AFL. Less efficient substrates are NECA, adenosine, 5′-methylthioadenosine, S-adenosylhomocysteine, 2′-deoxyadenosine, 3′-deoxyadenosine, 5′-deoxyadenosine and AMP. The kinetic constants are presented in Table 2. The values of kcat/Km with AFL for Sav2595, Acel0264, Dr0824 and Nis0429 are greater than 105 M−1 s−1.
Table 2.
Sav2595 | Acel0264 | Dr0824 | Nis0429 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||
kcat (s−1) | Km (μM) | kcat/Km (M−1s−1) | kcat (s−1) | Km (μM) | kcat/Km (M−1s−1) | kcat (s−1) | Km (μM) | kcat/Km (M−1s−1) | kcat (s−1) | Km (μM) | kcat/Km (M−1s−1) | |
AFL | 3.8 | 4.8 | 7.9 × 105 | 6.8 | 6.0 | 1.1 × 106 | 8.6 | 1.8 | 4.8 × 106 | 1.2 | 0.9 | 1.3 × 106 |
NECA | - | - | 34 | 0.007 | 61 | 110 | - | - | 1.0 × 104 | - | - | 110 |
5′-methylthioadenosine | 0.40 | 94 | 4.3 × 103 | - | - | 28 | - | - | 3.4 × 104 | 0.31 | 110 | 2.8 × 103 |
adenosine | - | - | 2.2 × 104 | - | - | 20 | - | - | 1.8 × 104 | - | - | 11 |
S-adenosylhomocysteine | - | - | 310 | - | - | 24 | - | - | 7.0 × 103 | - | - | 79 |
5′-deoxyadenosine | - | - | 2.9 × 103 | - | - | 47 | - | - | 7.4 × 104 | 0.017 | 42 | 410 |
3′-deoxyadenosine | - | - | 240 | - | - | 44 | - | - | 240 | - | - | 6 |
2′-deoxyadenosine | - | - | 1.1 × 103 | - | - | 51 | 0.72 | 37 | 1.9 × 104 | - | - | 5 |
AMP | - | - | 32 | - | - | 45 | - | - | 21 | - | - | 3 |
Standard errors on the kinetic constants are less than 15%. Assays were conducted at pH 7.5 and at 30 °C. Sav2595 is from group 13 of cog1816; Acel0264 is from group 11 of cog1816; Dr0824 is from group 41 of cog0402; and Nis0429 is from group 7 of cog0402.
Mutational Analysis
Single-site mutants of Sav2595 and Nis0429 were constructed to help identify residues that may interact with the side chain carboxylate of AFL. The R87A and R87M variants of Sav2595 were expressed in E. coli and subsequently purified. The S145A mutant of Nis0429 was constructed, expressed in E. coli, and purified. The mutant proteins were assayed, and the kinetic constants for the deamination of AFL and adenosine were determined. The results for the Sav2595 mutants are presented in Table 3. The Nis0429 S145A mutant has a kcat of 4.5 s−1, a KM of 12 μM and a kcat/KM of 3.8 × 105 M−1 s−1.
Table 3.
AFL | adenosine | |||||
---|---|---|---|---|---|---|
| ||||||
kcat (s−1) | Km (μM) | kcat/Km (M−1s−1) | kcat (s−1) | Km (μM) | kcat/Km (M−1s−1) | |
WT | 3.8 | 4.8 | 8 × 105 | - | - | 2.2 × 104 |
R87A | 0.094 | 3.4 | 2.7 × 104 | 0.106 | 8.3 | 1.3 × 104 |
R87M | 0.42 | 8 | 5.3 × 104 | 0.41 | 10 | 4.1 × 104 |
Standard errors on the kinetic constants are less than 15%. Assays were conducted at pH 7.5 and at 30 °C.
Structure of Nis0429
The crystal structure of Nis0429 (PDB ID: 3V7P) was determined at 1.35 Å resolution, revealing a slightly distorted TIM-barrel domain with a metal binding site and a much smaller β-barrel domain positioned between two short α-helices. The latter is comprised of both N-terminal (residues 1–54) and C-terminal (starting around residue 354) sequences. The likely biological assembly of Nis0429 is a C2-symmetrical homodimer (Figure 5), in which both domains are involved in formation of the dimer interface and maintenance of the active site architecture. Besides protein atoms and water molecules, the refined structure contains a few tightly bound ligands (listed in Table 1). The metal is coordinated to His-61, His-62, His-206 and water 608, which was modeled and refined as Fe2+ on the basis of coordination geometry and crystallographic refinement (Figure 6). However, the possibility exists that there is a mixture of metals in the active site, although refinement parameters and coordination geometry are more consistent with the presence of iron and thus the metal was modeled and refined as such. The difference between the metal analysis of the purified protein and the metal in the active site may be related to the crystallization conditions.
In addition to two small unknown ligands (refined as formic acid and glycine) inside the active site, strong electron density has revealed the presence of a larger molecule that was modeled and refined as benzoic acid (Figure 6). Based on the location of this particular ligand and using the coordinates of previously reported structures of adenosine deaminases, one AFL molecule was manually modeled into the active site of Nis0429. In the crystal structure, the carboxylic acid moiety of benzoic acid is coordinated by the side chain hydroxyl of Ser-145 from β-strand 3 and a water molecule. The same interactions can be mimicked by the 5′-side chain of AFL (Figure 7). The analogous residue position in all members of group 7 from cog0402 is either serine or threonine. Comparison of Nis0429 (PDB ID: 3V7P) with structures of adenosine deaminases revealed striking similarities between their highly conserved (>90%) metal and nucleoside binding sites (magenta, Figure 8). By contrast, the hydrophobic portion of the binding site is represented by mainly non-polar residues specific for Nis0429 and its closest homologues (yellow, Figure 8).
Structure of S145 Mutant of Nis0429
The crystals of wild-type Nis0429 and the S145A mutant were essentially isomorphous (Table 1) and their structures are very similar with one important difference: the orientation of the benzoic acid ligand bound inside the active site next to a residue 145 (Figure 9). In the wild-type protein the carboxyl moiety of the ligand is hydrogen-bonded to the Ser-145 side-chain hydroxyl group and a Gly-144 amide nitrogen, whereas in the mutant structure the same group is hydrogen-bonded to the side chain from Arg-89. Another interesting feature of the Ser-145 mutant is the presence of the metal ion (refined as Fe2+) in the active site. The high resolution structure revealed a slightly distorted tetrahedral metal ion coordination with varied distances between bonded atoms. The distances are as follows: 1.63 Å (Fe - water A962); 1.96 Å (Fe - His-61); 2.12 Å (Fe - His-63) and 2.33 Å (Fe – His-206). The side chain of Asp-306 is positioned in two alternate conformations, one of which may support a weak coordination bond to the iron at a distance of 2.52 Å.
Structure of Dr0824
The crystal structure of Dr0824 was determined by the SAD method and refined to 1.78 Å resolution (Table 1). Dr0824 consists of two domains, a distorted TIM-barrel domain and a small domain with a β-sheet flanked by a-helices on both sides. The small domain is made up of both the N-terminal (34 through 91) and C-terminal (399 through 413) residues. Residues 1 – 33, 47 – 49, and 395 – 396 have poor or undefined electron density. Missing residues 47 – 49 and 395 – 396 are located at the interface of the intra-molecular domains.
A metal ion is located at the C-terminal side of the β-sheet of the distorted TIM-barrel domain, which is the catalytic domain. The metal ion is coordinated with His-97 and His-99 of β-strand 1, His-238 of β-strand 6, and a water molecule (O554). Water molecule O554 also forms a hydrogen bond with OD1 of Asp-352 and is expected to be the nucleophilic center. Both N- and C-terminal sides of the distorted β-barrel of this catalytic domain are covered by α-helices and the active site is closed from outside interactions.
The crystallographic data support the conclusion that the biological assembly for this protein is a monomer rather than a homodimer. Excluding the unique N-terminal sequence fragment (~50 residues), the Dr0824 structure shows a high degree of similarity to Nis0429 (Figure 10) with RMSD between Cα atoms along the aligned length (residues 54–274) of about 2.1 Å. The only large difference between these two structures is the conformation of the two segments near the active site pocket (residues 102–128 and 253–283, colored blue in the 2IMR structure in Figure 10. The observed differences may be the result of crystal packing, loops flexibility, or the presence of ligands bound in the substrate-binding site of Nis0429.
Docking Poses of AFL in Sav2595 and Acel0264
In docking screens, the chiral tetrahedral intermediate for the deamination reaction that was generated by the attack of hydroxide on the re-face of the adenine moiety of AFL was ranked 51 and 30 among the 57,680 high-energy intermediates (HEI) in the virtual substrate library for Acel0264 and Sav2595, respectively. In the modeled active site of Sav2595 from cog1816, the metal ion is coordinated by three histidine residues (His-32, His-34, and His-215) and one aspartate residue (Asp-296). This catalytic machinery is conserved in Dr0824 and Nis0429 from cog0402. The modeled active site of Sav2595 shows the two hydroxyl groups from the ribose moiety of AFL forming hydrogen bonds with the side chain carboxylate group from Asp-154. This interaction is also identified in the docking of AFL to Nis0429 (Glu-141). The N3 nitrogen from the adenine moiety of AFL forms a hydrogen bond with the backbone amine group from Gly-188, but this interaction is replaced by a histidine residue in Nis0429 (His-179). The AFL specificity of Sav2595 can be explained by the presence of an arginine residue (Arg-87) that interacts with the carboxylate group in the 3-ketobenzoic acid moiety of AFL (Figure 11). In Nis0429, Ser-145 is predicted to hydrogen bond to the 3-ketobenzoic acid moiety (Figure 8).
DISCUSSION
Utilization of Bioinformatics, Structural Biology, and Molecular Enzymology to Determine Substrate Specificity
A group of bacterial deaminases from cog1816 and cog0402 within the amidohydrolase superfamily of enzymes has been characterized. These enzymes are currently incorrectly annotated as adenosine deaminases and chlorohydrolases. The most likely physiological substrate is 6-aminodeoxyfutalosine (AFL). AFL is an intermediate in the biosynthesis of menaquinone in certain bacteria that utilize the futalosine pathway (4). Further evidence supporting a role in the futalosine pathway is the location of Acel0264 in a cluster of genes related to the biosynthesis of menaquinone (Figure 2). The gene for Acel0264 is flanked by the genes for Acel0261 and Acel0263. These two genes are orthologs to MqnA and MqnC, respectively. Other members of group 11 from cog1816 have only UbiE, a methyltransferase in menaquinone biosynthesis, and cog-FixC, a geranylgeranyl reductase, as recurring neighbors. Members of group 13 of cog1816 and groups 7 and 41 of cog0402 show no genomic hints related to menaquinone biosynthesis, except for the lack of men gene homologs and the presence of mqn homologs.
Sequence Comparison and Structural Analysis
The four enzymes in group 11 of cog1816 share sequence identity to one another of greater than 50%, but are less than 30% identical to the well-characterized adenosine deaminase from E. coli (locus tag: b1623) from group 5 of cog1816. The same degree of similarity is observed between members of group 13. All of the residues that coordinate the divalent metal ion in the active site are conserved among the group 5, 11 and 13 enzymes, which include the HxH motif following β-strand 1, the histidine at the C-terminus of β-strand 5 and the aspartate at the C-terminus of β-strand 8. Another mutually conserved aspartate following β-strand 8 is responsible for hydrogen bonding to N7 of the adenine ring. Also conserved among these deaminases from cog1816 is the glutamate from the HxxE motif at the C-terminus of β-strand 5. A functionally important and conserved histidine at the C-terminus of β-strand 6 forms a hydrogen bond with the putative hydrolytic water and may participate in proton transfer reactions.
Unlike other members of cog1816, members of group 11 and 13 have a conserved arginine following β-strand 1. Using adenosine deaminase (PDB ID: 1KRM) as a structural template, a model was constructed in an attempt to understand the substrate specificity of Acel0264 and Sav2595. An arginine residue was identified that could possibly recognize the carboxylate group of the 5′-side chain of AFL. The predicted location of Arg-87 in Sav2595 is on a turn between two α-helices after β-strand 1. This arginine was mutated to alanine or methionine in Sav2595, resulting in slower rates for the deamination of AFL, with essentially no effect on KM (Table 3). The R87A and R87M mutants could be saturated with adenosine, whereas the wild-type enzyme was not. From these results, we propose that Arg-87 is likely near the substrate binding site (Figure 11) because changing this residue leads to the loss of substrate specificity. The remainder of the large substrate binding pocket is made up of hydrophobic residues and an aspartate or glutamate to interact with the 2′-hydroxyl group.
Members of group 7 of cog0402 share a sequence identity of 40% or more within the group, but much less than 30% with atrazine chlorohydrolase, and less than 25% compared to guanine deaminases from group 2. Dr0824 has a sequence identity of 25% or less with members of group 7 of cog0402, and has very low sequence similarity to well-characterized members of cog0402 and groups 11 and 13 of cog1816. Active site residues involved in metal binding are conserved among group 7 and 41 members, including an HxH motif after β-strand 1, another histidine after β-strand 5 and an aspartate after β-strand 8. A histidine after β-strand 6 is associated with binding a hydrolytic water molecule. A catalytically essential glutamate is conserved after β-strand 5. Additional shared substrate recognition elements include a glutamate after β-strand 1 involved in binding of the 3′-hydroxyl group of the ribose moiety and a histidine after β-strand 4 responsible for hydrogen bonding to N3 of the purine ring system of a nucleoside substrate.
The active site structure of Nis0429 (PDB ID: 3V7P) is shown in Figure 6 and the complete structure is shown in Figure 7 with AFL manually docked in the active site. The placement of AFL in the active site of Nis0429 was guided by the position of benzoic acid in the structure of this protein and the binding of adenosine in the active site of adenosine deaminases. This binding mode predicts an interaction with Ser-145 after β-strand 3 to bind the side chain of AFL (Figure 8). A serine or threonine residue is conserved in this position in all members of group 7 of cog0402, but not in group 41 or groups 11 and 13 of cog1816. It is noteworthy that the S145A mutation of Nis0429 has resulted in more than a 10-fold higher KM value than that of the wild-type enzyme. These data support the idea that Ser-145 is directly involved in binding of AFL.
We have demonstrated that Acel0264, Sav2595, Nis0429 and Dr0824 are not adenosine deaminases or chlorohydrolases, as currently annotated. Based on sequence similarity and conservation of putative essential residues, all known members of groups 11 and 13 of cog1816 and groups 7 and 41 of cog0402 are probable 6-aminodeoxyfutalosine deaminases. It is quite likely that these enzymes evolved from distinct deaminases, which may explain the variation in observed enzyme architecture. On the basis of our data, we propose a list of proteins believed to be 6-aminodeoxyfutalosine deaminase enzymes (Table 4). The presence of an AFL deaminase in certain organisms is surprising to some degree because Campylobacter jejuni has been reported to have a methylthioadenosine nucleosidase (MTAN) that will hydrolyze AFL directly to the MqnB product (Figure 1) but will not hydrolyze futalosine (25). C. jejuni MTAN is the only close relative for futalosine hydrolase (MqnB) activity in the genome. It is unclear why organisms would have an AFL deaminase, if they do not also have a futalosine hydrolase. Perhaps the AFL deaminase gene is a remnant of the original futalosine pathway in these organisms.
Table 4.
Organism | Locus Tag | GI | cog |
---|---|---|---|
Acidothermus cellulolyticus 11B | Acel_0264 | 117927473 | 1816 |
Arcobacter butzleri RM018 | Abu_0489 | 157736750 | 0402 |
Campylobacter concisus 13826 | CCC13826_0371 | 157164865 | 0402 |
Campylobacter curvus 525.92 | CCV52592_0362 | 154174508 | 0402 |
Campylobacter fetus subsp. fetus 82–40 | CFF8240_1504 | 118475030 | 0402 |
Campylobacter hominis ATCC BAA_381 | CHAB381_1212 | 154147820 | 0402 |
Campylobacter jejuni NCTC 11168 | Cj0067 | 15791459 | 0402 |
Campylobacter jejuni RM1221 | CJE0064 | 57237077 | 0402 |
Campylobacter jejuni subsp. 81–176 | CJJ81176_0105 | 121612374 | 0402 |
Campylobacter jejuni subsp. doylei 269.97 | JJD26997_0077 | 153952082 | 0402 |
Campylobacter jejuni subsp. jejuni 81116 | C8J_0060 | 157414381 | 0402 |
Campylobacter lari RM1200 | Cla_0229 | 222823270 | 0402 |
Deinococcus deserti VCD115 | Deide_06659 | 226355533 | 0402 |
Deinococcus geothermalis DSM 11300 | Dgeo_0576 | 94984683 | 0402 |
Deinococcus radiodurans R1 | Dr0824 | 15805850 | 0402 |
Frankia alni ANC14a | FRAAL1027 | 111220494 | 1816 |
Frankia sp. Ccl3 | Francci3_0534 | 86739247 | 1816 |
Frankia sp. EAN1pec | Franean1_6098 | 158317840 | 1816 |
Frankia sp. EAN1pec | Franean1_2196 | 158314030 | 1816 |
Helicobacter hepaticus ATCC 51449 | HH1764 | 32267263 | 0402 |
Nautilia profundicola AmH | NAMH_1355 | 224373376 | 0402 |
Nitratiruptor sp. SB155-2 | NIS_0429 | 152990178 | 0402 |
Nocardioides sp. JS614 | Noca_1355 | 119715591 | 1816 |
Salinospora arenicola CNS-205 | Sare_1766 | 159037391 | 1816 |
Salinospora tropica CNB-440 | Strop_1779 | 145594323 | 1816 |
Streptomyces avermitilis MA-4680 | Sav_2595 | 29829137 | 1816 |
Streptomyces coelicolor A3(2) | Sco5662 | 21224013 | 1816 |
Streptomyces griseus subsp. griseus NBRC 13359 | SGR_1841 | 182435634 | 1816 |
Sulfurimonas denitrificans DSM 1251 | Suden_0686 | 78776885 | 0402 |
Sulfurovum sp. NBC37-1 | SUN_1037 | 152992630 | 0402 |
Wolinella succinogenes DSM 1740 | WS1477 | 34557817 | 0402 |
Comparison to Adenosine Deaminase from cog1816
The prototypical adeonosine deaminase from E. coli (locus tag: b1623) is also a member of the amidohydrolase superfamily and cog1816. This enzyme has a mononuclear metal center and will deaminate adenosine, N-6-methyladenosine, and 2′-deoxyadenosine as substrates with comparable rate constants. With the high conservation of metal-binding and catalytically essential residues between Acel0264, Sav2595, and b1623, it is very likely that these enzymes will employ the same mechanism for deamination. Dr0824 and Nis0429 have a slightly modified nucleoside binding site compared to b1623, but the structures and the biochemical data clearly support the notion that they function through an activated water molecule to facilitate the deamination reaction.
Acidothermus celluloyticus 11B has a protein from cog0402 (Acel1042) of unknown function, and no other proteins in cog1816 or cog1001, and thus adenosine or adenine deaminases are not likely to be found in this organism. The genome of Streptomyces avermitilis MA-4680 contains five proteins from cog1816 and four proteins from cog0402. Of the five proteins from cog1816, Sav5577 is a confirmed adenine deaminase belonging to group 3, Sav1165 and Sav3358 are believed to be adenosine deaminases from group 1, and Sav4906 from group 17 has unknown function. The genes from cog0402 include an isoxanthopterin deaminase (Sav2017) and Sav4899, Sav6652, and Sav3494 of unknown function. Deinococcus radiodurans R1 has an adenine deaminase from cog1001 (DrA0270) and a guanine deaminase from cog0402 (DrA0180) in addition to Dr0824. Nis0429 is the sole protein in Nitratiruptor sp. SB155-2 from cog0402, cog1816 or cog1001.
Strategy for Annotation and Characterization
Acidothermus celluloyticus 11B, Streptomyces avermitilis MA-4680, Nitratiruptor sp. SB155-2, and Deinococcus radiodurans R1 were identified as lacking the men genes necessary for menaquinone biosynthesis. The genes involved in an alternative menaquinone biosynthetic pathway were identified in clusters in the Acidothermus celluloyticus 11B genome and we have confirmed that Acel0264 was capable of deaminating 6-aminodeoxyfutalosine. The genomes of Nitratiruptor sp. SB155-2, Streptomyces avermitilis MA-4680, and Deinococcus radiodurans R1 lacked the men genes associated with the shikimate pathway, but they do possess the mqn genes of the futalosine pathway. A sequence similarity network was constructed and used to identify additional proteins with similar sequences to Acel0264, Sav2595, Dr0824, and Nis0429. Substrate profiles for these proteins were determined using a small focused library and a model for substrate binding was proposed. The high resolution crystal structure of Nis0429 with smaller ligands in the active site helped us to predict the binding mode of AFL as a substrate.
Acknowledgments
FUNDING
This work was supported in part by the Robert A. Welch Foundation (A-840) and the NIH (GM 71790). This work was made possible by the Center for Synchrotron Biosciences grant, P30-EB-009998, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB). Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-98CH10886.
ABBREVIATIONS
- ADE
adenine deaminase
- ADD
adenosine deaminase
- cog
cluster of orthologous groups
- IPTG
isopropyl-β-galactoside
- DTT
dithiothreitol
- AHS
amidohydrolase superfamily
- ICP-MS
inductively coupled plasma mass spectrometry
- NECA
1-(6-amino-9H-purin-9-yl)-1-deoxy-N-ethyl-β-D-ribofuranuronamide
- SAH
S-adenosylhomocysteine
- AFL
6-aminodeoxyfutalosine
References
- 1.Hiratsuka T, Furihata K, Ishikawa J, Yamashita H, Itoh N, Seto H, Dairi T. An alternative menaquinone biosynthetic pathway operating in microorganisms. Science. 2008;321:1670–1673. doi: 10.1126/science.1160446. [DOI] [PubMed] [Google Scholar]
- 2.Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A, Brown S, Chandra G, Chen CW, Collins M, Cronin A, Fraser A, Goble A, Hidalgo J, Hornsby T, Howarth S, Huang CH, Kieser T, Larke L, Murphy L, Oliver K, O’Neil S, Rabbinowitsch E, Rajandream MA, Rutherford K, Rutter S, Seeger K, Saunders D, Sharp S, Squares R, Squares S, Taylor K, Warren T, Wietzorrek A, Woodward J, Barrell BG, Parkhill J, Hopwood DA. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2) Nature. 2002;417:141–147. doi: 10.1038/417141a. [DOI] [PubMed] [Google Scholar]
- 3.Borodina I, Krabben P, Nielsen J. Genome-scale analysis of Streptomyces coelicolor A3(2) metabolism. Genome research. 2005;15:820–829. doi: 10.1101/gr.3364705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Arakawa C, Kuratsu M, Furihata K, Hiratsuka T, Itoh N, Seto H, Dairi T. Diversity of the early step of the futalosine pathway. Antimicrobial agents and chemotherapy. 2011;55:913–916. doi: 10.1128/AAC.01362-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Holm L, Sander C. An evolutionary treasure: unification of a broad set of amidohydrolases related to urease. Proteins. 1997;28:72–82. [PubMed] [Google Scholar]
- 6.Seibert CM, Raushel FM. Structural and catalytic diversity within the amidohydrolase superfamily. Biochemistry. 2005;44:6383–6391. doi: 10.1021/bi047326v. [DOI] [PubMed] [Google Scholar]
- 7.Kamat SS, Fan H, Sauder JM, Burley SK, Shoichet BK, Sali A, Raushel FM. Enzymatic deamination of the epigenetic base N-6-methyladenine. Journal of the American Chemical Society. 2011;133:2080–2083. doi: 10.1021/ja110157u. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hall RS, Agarwal R, Hitchcock D, Sauder JM, Burley SK, Swaminathan S, Raushel FM. Discovery and structure determination of the orphan enzyme isoxanthopterin deaminase. Biochemistry. 2010;49:4374–4382. doi: 10.1021/bi100252s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Goble AM, Zhang Z, Sauder JM, Burley SK, Swaminathan S, Raushel FM. Pa0148 from Pseudomonas aeruginosa catalyzes the deamination of adenine. Biochemistry. 2011;50:6589–6597. doi: 10.1021/bi200868u. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Goble AM, Fan H, Sali A, Raushel FM. Discovery of a cytokinin deaminase. ACS chemical biology. 2011;6:1036–1040. doi: 10.1021/cb200198c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wang Z, Quiocho FA. Complexes of adenosine deaminase with two potent inhibitors: X-ray structures in four independent molecules at pH of maximum activity. Biochemistry. 1998;37:8314–8324. doi: 10.1021/bi980324o. [DOI] [PubMed] [Google Scholar]
- 12.Ho MC, Cassera MB, Madrid DC, Ting LM, Tyler PC, Kim K, Almo SC, Schramm VL. Structural and metabolic specificity of methylthiocoformycin for malarial adenosine deaminases. Biochemistry. 2009;48:9618–9626. doi: 10.1021/bi9012484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Baer HP, Drummond GI, Gillis J. Studies on the specificity and mechanism of action of adenosine deaminase. Arch Biochem Biophys. 1968;123:172–178. doi: 10.1016/0003-9861(68)90116-1. [DOI] [PubMed] [Google Scholar]
- 14.Kinoshita T, Nakanishi I, Terasaka T, Kuno M, Seki N, Warizaya M, Matsumura H, Inoue T, Takano K, Adachi H, Mori Y, Fujii T. Structural basis of compound recognition by adenosine deaminase. Biochemistry. 2005;44:10562–10569. doi: 10.1021/bi050529e. [DOI] [PubMed] [Google Scholar]
- 15.Kinoshita T, Tada T, Nakanishi I. Conformational change of adenosine deaminase during ligand-exchange in a crystal. Biochem Biophys Res Commun. 2008;373:53–57. doi: 10.1016/j.bbrc.2008.05.180. [DOI] [PubMed] [Google Scholar]
- 16.Koch AL, Vallee G. The properties of adenosine deaminase and adenosine nucleoside phosphorylase in extracts of Escherichia coli. J Biol Chem. 1959;234:1213–1218. [PubMed] [Google Scholar]
- 17.Lin J, Westler WM, Cleland WW, Markley JL, Frey PA. Fractionation factors and activation energies for exchange of the low barrier hydrogen bonding proton in peptidyl trifluoromethyl ketone complexes of chymotrypsin. Proc Natl Acad Sci U S A. 1998;95:14664–14668. doi: 10.1073/pnas.95.25.14664. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Gleeson MP, Burton NA, Hillier IH. Prediction of the potency of inhibitors of adenosine deaminase by QM/MM calculations. Chem Commun (Camb) 2003:2180–2181. doi: 10.1039/b305790a. [DOI] [PubMed] [Google Scholar]
- 19.Sadat Hayatshahi SH, Abdolmaleki P, Ghiasi M, Safarian S. QSARs and activity predicting models for competitive inhibitors of adenosine deaminase. FEBS Lett. 2007;581:506–514. doi: 10.1016/j.febslet.2006.12.050. [DOI] [PubMed] [Google Scholar]
- 20.Wilson DK, Rudolph FB, Quiocho FA. Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. Science. 1991;252:1278–1284. doi: 10.1126/science.1925539. [DOI] [PubMed] [Google Scholar]
- 21.Larson ET, Deng W, Krumm BE, Napuli A, Mueller N, Van Voorhis WC, Buckner FS, Fan E, Lauricella A, DeTitta G, Luft J, Zucker F, Hol WG, Verlinde CL, Merritt EA. Structures of substrate- and inhibitor-bound adenosine deaminase from a human malaria parasite show a dramatic conformational change and shed light on drug selectivity. J Mol Biol. 2008;381:975–988. doi: 10.1016/j.jmb.2008.06.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Weiss PM, Cook PF, Hermes JD, Cleland WW. Evidence from nitrogen-15 and solvent deuterium isotope effects on the chemical mechanism of adenosine deaminase. Biochemistry. 1987;26:7378–7384. doi: 10.1021/bi00397a027. [DOI] [PubMed] [Google Scholar]
- 23.Sideraki V, Mohamedali KA, Wilson DK, Chang Z, Kellems RE, Quiocho FA, Rudolph FB. Probing the functional role of two conserved active site aspartates in mouse adenosine deaminase. Biochemistry. 1996;35:7862–7872. doi: 10.1021/bi952920d. [DOI] [PubMed] [Google Scholar]
- 24.Atkinson HJ, Morris JH, Ferrin TE, Babbitt PC. Using sequence similarity networks for visualization of relationships across diverse protein superfamilies. PLoS One. 2009;4:e4345. doi: 10.1371/journal.pone.0004345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Li X, Apel D, Gaynor EC, Tanner ME. 5′-methylthioadenosine nucleosidase is implicated in playing a key role in a modified futalosine pathway for menaquinone biosynthesis in Campylobacter jejuni. J Biol Chem. 2011;286:19392–19398. doi: 10.1074/jbc.M111.229781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Aslanidis C, de Jong PJ. Ligation-independent cloning of PCR products (LIC-PCR) Nucleic acids research. 1990;18:6069–6074. doi: 10.1093/nar/18.20.6069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Hall RS, Xiang DF, Xu C, Raushel FM. N-Acetyl-D-glucosamine-6-phosphate deacetylase: substrate activation via a single divalent metal ion. Biochemistry. 2007;46:7942–7952. doi: 10.1021/bi700543x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. Jalview Version 2--a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25:1189–1191. doi: 10.1093/bioinformatics/btp033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–1797. doi: 10.1093/nar/gkh340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Sali A, Blundell TL. Comparative Protein Modeling by Satisfaction of Spatial Restraints. J Mol Biol. 1993;234:779–815. doi: 10.1006/jmbi.1993.1626. [DOI] [PubMed] [Google Scholar]
- 31.Shen MY, Sali A. Statistical potential for assessment and prediction of protein structures. Protein Science. 2006;15:2507–2524. doi: 10.1110/ps.062416606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Sherman W, Day T, Jacobson MP, Friesner RA, Farid R. Novel procedure for modeling ligand/receptor induced fit effects. J Med Chem. 2006;49:534–553. doi: 10.1021/jm050540c. [DOI] [PubMed] [Google Scholar]
- 33.Lorber DM, Shoichet BK. Hierarchical docking of databases of multiple ligand conformations. Current Topics in Medicinal Chemistry. 2005;5:739–749. doi: 10.2174/1568026054637683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Mysinger MM, Shoichet BK. Rapid Context-Dependent Ligand Desolvation in Molecular Docking. J Chem Inf Model. 2010;50:1561–1573. doi: 10.1021/ci100214a. [DOI] [PubMed] [Google Scholar]
- 35.Hermann JC, Ghanem E, Li YC, Raushel FM, Irwin JJ, Shoichet BK. Predicting substrates by docking high-energy intermediates to enzyme structures. J Am Chem Soc. 2006;128:15882–15891. doi: 10.1021/ja065860f. [DOI] [PubMed] [Google Scholar]
- 36.Hermann JC, Marti-Arbona R, Fedorov AA, Fedorov E, Almo SC, Shoichet BK, Raushel FM. Structure-based activity prediction for an enzyme of unknown function. Nature. 2007;448:775–779. doi: 10.1038/nature05981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Fan H, Hitchcock D, Seidel RD, Hillerich B, Lin H, Almo SC, Sali A, Shoichet BK, Raushel FM. Assignment of pterin deaminase activity to an enzyme of unknown function guided by homology modeling and docking. J Am Chem Soc. 2013;135:795–803. doi: 10.1021/ja309680b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28:27–30. doi: 10.1093/nar/28.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006;34:D354–D357. doi: 10.1093/nar/gkj102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307–326. doi: 10.1016/S0076-6879(97)76066-X. [DOI] [PubMed] [Google Scholar]
- 41.De-La-Fortelle E, Bricogne G. Maximum-likelihood heavy atom parameter refinement in the MIR and MAD methods. Methods Enzymol. 1997;276:472–493. doi: 10.1016/S0076-6879(97)76073-7. [DOI] [PubMed] [Google Scholar]
- 42.Terwilliger TC, Berendzen J. Automated structure solution for MIR and MAD. Acta Cryst D. 1997;55:849–861. doi: 10.1107/S0907444999000839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Perrakis A, Morris R, Lamzin VS. Automated protein model building combined with iterative structure refinement. Nature Struct Biol. 1999;6:458–463. doi: 10.1038/8263. [DOI] [PubMed] [Google Scholar]
- 44.Jones TA, Zou J-Y, Cowan SW, Kjeldgaard M. Improved methods in building protein models in electron density map and the location of errors in these models. Acta Crystallogr. 1991;A47:110–119. doi: 10.1107/s0108767390010224. [DOI] [PubMed] [Google Scholar]
- 45.Brunger AT, Adams PD, Clore GM, Delano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszwewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Somonsom T, Warren GL. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D. 1998;54:905–921. doi: 10.1107/s0907444998003254. [DOI] [PubMed] [Google Scholar]
- 46.Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AG, McCoy A, McNicholas SJ, Murshudov GN, Pannu NS, Potterton EA, Powell HR, Read RJ, Vagin A, Wilson KS. Overview of the CCP4 suite and current developments. Acta crystallographica Section D, Biological crystallography. 2011;67:235–242. doi: 10.1107/S0907444910045749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Collaborative Computational Project Number 4. The CCP4 suite: programs for protein crystallography. Acta Cryst. 1994;D50:760–763. doi: 10.1107/S0907444994003112. [DOI] [PubMed] [Google Scholar]
- 48.Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta crystallographica Section D, Biological crystallography. 1997;53:240–255. doi: 10.1107/S0907444996012255. [DOI] [PubMed] [Google Scholar]
- 49.Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta crystallographica Section D, Biological crystallography. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]